STAT3 gain-of-function variants and T cell-mediated inflammation

被引：0

作者：

Toth, Kelsey A. ^{[1
]}

Saucier, Nermina ^{[1
]}

Agbigbe, Tejiri ^{[1
]}

Schmitt, Erica ^{[1
]}

Keppel, Molly P. ^{[1
]}

Klechevsky, Eynav ^{[1
]}

Kim, Brian ^{[1
]}

Cooper, Megan A. ^{[1
]}

机构：

[1] Washington Univ, Sch Med, St Louis, MO USA

来源：

JOURNAL OF IMMUNOLOGY | 2021年 / 206卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

61.14

引用

页数：2

共 50 条

[31] Successful Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK Inhibitors
Silva-Carmona, Manuel
Vogel, Tiphanie P.
Marchal, Sarah
Guesmi, Myriam
Dubus, Jean-Christophe
Leroy, Sylvie
Fabre, Alexandre
Barlogis, Vincent
Forbes, Lisa R.
Giovannini-Chami, Lisa
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (06) : 893 - 897
[32] Severe infantile-onset autoimmune hypothyroidism secondary to STAT3 gain-of-function mutation
Damilano, Cecilia
Lndyk, Justin
Akoghlanian, Shoghik
Bartholomew, Dennis
Ciciora, Steven
Bowden, Sasigam A.
HORMONE RESEARCH IN PAEDIATRICS, 2020, 93 : 145 - 145
[33] Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations
Milner, Joshua D.
Vogel, Tiphanie P.
Forbes, Lisa
Ma, Chi A.
Stray-Pedersen, Asbjorg
Niemela, Julie E.
Lyons, Jonathan J.
Engelhardt, Karin R.
Zhang, Yu
Topcagic, Nermina
Roberson, Elisha D. O.
Matthews, Helen
Verbsky, James W.
Dasu, Trivikram
Vargas-Hernandez, Alexander
Varghese, Nidhy
McClain, Kenneth L.
Karam, Lina B.
Nahmod, Karen
Makedonas, George
Mace, Emily M.
Sorte, Hanne S.
Perminow, Gori
Rao, V. Koneti
O'Connell, Michael P.
Price, Susan
Su, Helen C.
Butrick, Morgan
McElwee, Joshua
Hughes, Jason D.
Willet, Joseph
Swan, David
Xu, Yaobo
Santibanez-Koref, Mauro
Slowik, Voytek
Dinwiddie, Darrell L.
Ciaccio, Christina E.
Saunders, Carol J.
Septer, Seth
Kingsmore, Stephen F.
White, Andrew J.
Cant, Andrew J.
Hambleton, Sophie
Cooper, Megan A.
BLOOD, 2015, 125 (04) : 591 - 599
[34] Successful treatment of oral potentially malignant lesions with ruxolitinib in STAT3 gain-of-function disease
Mulvihill, Ciara
Fitzgerald, Kirsten
O'Regan, Esther
Healy, Claire M.
Leahy, Timothy Ronan
ORAL ONCOLOGY, 2022, 132
[35] ADULT MALE WITH STAT3 GAIN-OF-FUNCTION MUTATION PREVIOUSLY DIAGNOSED AS COMMON VARIABLE IMMUNODEFICIENCY
Buckley, R.
Wang, E.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S120 - S120
[36] A patient-based murine model recapitulates human STAT3 gain-of-function syndrome
Meesilpavikkai, Kornvalee
Zhou, Zijun
Kaikaew, Kasiphak
Phakham, Suphattra
van der Spek, Peter J.
Swagemakers, Sigrid
Venter, Deon J.
de Bie, Maaike
Schrijver, Benjamin
Schliehe, Christopher
Kaiser, Fabian
Dalm, Virgil A. S. H.
van Hagen, P. Martin
Hirankarn, Nattiya
Ijspeert, Hanna
Dik, Willem A.
CLINICAL IMMUNOLOGY, 2024, 266
[37] Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation
Wenjie Wang
Luyao Liu
Xiaoying Hui
Ying Wang
Wenjing Ying
Qinhua Zhou
Jia Hou
Mi Yang
Bijun Sun
Jinqiao Sun
Xiaochuan Wang
BMC Immunology, 22
[38] Early-onset, fatal interstitial lung disease in STAT3 gain-of-function patients
Gothe, Florian
Gehrig, Jonathan
Rapp, Christina K.
Knoflach, Katrin
Reu-Hofer, Simone
Langer, Florian
Schramm, Dirk
Ley-Zaporozhan, Julia
Ehl, Stephan
Schwerk, Nicolaus
Faletti, Laura
Griese, Matthias
PEDIATRIC PULMONOLOGY, 2021, 56 (12) : 3934 - 3941
[39] Germline STAT3 gain-of-function mutations in primary immunodeficiency: Impact on the cellular and clinical phenotype
Faletti, Laura
Ehl, Stephan
Heeg, Maximilian
BIOMEDICAL JOURNAL, 2021, 44 (04) : 412 - 421
[40] STAT3 Gain-of-function Syndrome Mutations Are Susceptible to JAK Inhibition Despite a Spectrum of Potency
Ona, Herda
Branch, Justin
Osuna, Isabella
Vasquez, Priscilla
Reyes, Anaid
Baker, Phillip
Clowers, Michael
Wood, Stephanie
Vogel, Tiphanie
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 73 - 73

← 1 2 3 4 5 →